Piper Sandler Initiates Coverage On InspireMD with Overweight Rating, Announces Price Target of $3
Portfolio Pulse from richadhand@benzinga.com
Piper Sandler analyst Adam Maeder initiates coverage on InspireMD (NASDAQ:NSPR) with an Overweight rating and announces a price target of $3.
June 12, 2023 | 9:51 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Piper Sandler initiates coverage on InspireMD with an Overweight rating and a price target of $3.
The initiation of coverage by Piper Sandler with an Overweight rating and a price target of $3 indicates a positive outlook for InspireMD. This news is likely to have a positive impact on the stock price in the short term as it reflects the analyst's confidence in the company's potential growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100